CancerMath [33,42] is composed of five online tools which predict the clinical outcome for individual cancer patients, as well as for accurately estimating the potential benefits of treatment with endocrine therapy and chemotherapy based on age, HER-2 status, tumour size, number of positive lymph nodes, tumour phenotype, and grade. This evidence concerns the gene ERBB2 and cancer.